AIOCD – Pranic forays into UAE through Pranic Drug Store
Dubai, United Arab Emirates, 17th November 2022: All India Organisation of Chemist and Druggist (AIOCD), along with Pranic Drug Store today announced that it has expanded its presence internationally through its subsidiary entity Pranic Drug and has opened an office in Dubai, U.A.E.
Mr. Jagannath Sakharam Shinde, President, All India Organisation of Chemist and Druggist (AIOCD), Mr. Anish Shaikh, CEO, Pranic Drug Store, Mr. Abdulla Bin Souqat, Executive Director at Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, Mr. Mohammed Al Hashimi, Director of Project Management – Wasl Asset Management Group and Mr. Emad Berakdar, COO, Pranic Drug Store were present for the opening ceremony of their new office.
With an employee strength of 50+ people, Pranic Drug Store’s office located at Business Towers, Burjuman, will work as a subsidiary of AIOCD in the UAE, representing Indian pharmaceutical industries in the UAE. This newly opened office aims to support the Indian pharmaceutical manufacturers who do not have a presence in the region.
Mr. Jagannath Sakharam Shinde, President, All India Organisation of Chemist and Druggist (AIOCD), said, “AIOCD has the highest number of pharmacies under its umbrella. We are extremely proud to expand our presence internationally and set up an office through Pranic Drug Store within the United Arab Emirates. We are confident of working closely with UAE authorities to fill the gap and ensure Pranic Drug Store operates as a single window solution for Indian pharmaceutical companies.”
Mr. Anish Shaikh, CEO, Pranic Drug Store, said, “This is a significant milestone for us. We are delighted to be representatives of the $50 billion-dollar Indian pharmaceutical industry in the UAE. Our vision is in line with His Highness Sheikh Mohammed bin Rashid Al Maktoum’s vision for UAE for the next 50 years, which includes Health as a large part of his plan and it excites us to be part of this vision and establish our presence in the UAE, where we will support the UAE in providing medicines at the Right time, Right place, and Right price.
Catering to the market demand, Pranic Drug Store intends to make homeopathic, ayurvedic and other alternative medicines available as well at an affordable cost. AIOCD in conjunction with Pranic Drug Store plan to penetrate other Middle East countries and establish presence in Bahrain, Oman, Kingdom of Saudi Arabia, and Kuwait in the long run.
Commenting on the opening, Mr. Emad Berakdar, COO, Pranic Drug Store, said, “The UAE is an important market for us, Since UAE is the best platform globally, for all who are looking for an international expansion, the UAE was the most obvious choice for us. Pranic Drug Store is responsible for executing AIOCD’s vision in the UAE, in line with UAE government’s Vision 2071. We look forward to strengthening our presence in the region and supporting the growth of the pharmaceutical industry in the country.”
About AIOCD –
AIOCD Ltd (All India Origin Chemists & Druggists Ltd) is a 4 decade old public company with verticals ranging from manufacturing, distribution and licensing of pharmaceuticals, vaccines, medical devices , topical , other verticals being inventory management & demand planning (JIT – just in time logistics) and software development for healthcare industry.
Pranic Drug Store LLC is a company based in UAE and a subsidiary of Pranic group of companies a 2-decade old organization based in India with multi-sectoral presence and has merged with AIOCD for expansion into UAE.
About Pranic Drug –
AIOCD is also instrumental in shaping the pharmaceutical landscape of India with long standing partnerships with all manufacturers in India.
AIOCD-PRANIC is currently having exclusive agreements with various large pharmaceutical companies for preferential allocation for the UAE market in times of supply chain constraints and disruptions due to man-made or natural disasters.
AIOCD-PRANIC operates out of the mainland and has infrastructure and offices in India.
AIOCD-PRANIC owns & works with USFDA/MHRA/ANVISA/EU-GMP registered facilities for manufacturing and is present in north America, EU, Australia, Africa and ASEAN region.
